期刊文献+

基于外标记的图像配准在放射免疫显像图像融合中的应用 被引量:5

Application of external fiducial frame-based image registration in the fusion of radioimmunoimaging
下载PDF
导出
摘要 目的:本研究旨在验证外基准标记物在肿瘤患者单光子发射计算机断层术(single photon emission computed tomo-graphy,SPECT)放射免疫显像与CT图像融合中的临床应用价值。方法:将外标记物固定于6例肿瘤患者背部体表后,分别行SPECT放射免疫显像和CT扫描,并行图像配准融合。结果:6例患者的放射免疫显像图像能够精确地与CT图像进行融合,肿瘤病灶定位准确。结论:通过外标记物配准可以实现放射免疫显像与解剖显像图像进行融合,提高诊断定位的精确性。 Objective : To validate the clinical value of external fiducial frame in the fusion of single photon emission computed tomography (SPECT) radioimmunoimaging and CT imaging in tumor patients. Methods: The external fiducial frame was fixed on the body surface of back of the 6 patients. SPECT radioimmunoimaging and CT scan were performed on the 6 patients. The two styles of image were fused on the PC computer. Results: The images produced by SPECT radioimmunoimaging of the 6 patients were exactly fused with the CT image. The tumor lesions were correctly focused. Conclusion: The fusion of radioimmunoimaging and anatomic imaging would be accomplished by using the external fiduciat frame. Image fusion increases the accuracy of location diagnosis.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第12期1099-1101,共3页 Tumor
基金 上海市科技发展基金项目(编号:024119102)
关键词 放射免疫显像 ^99MTC 图像处理 计算机辅助 Radioimmunodetection ^99mTc Image processing, computer assisted
  • 相关文献

参考文献4

二级参考文献5

共引文献9

同被引文献49

  • 1王军伟,师建国,汪静,刘彦仿.^(99m)Tc标记抗肝癌单链抗体的生物分布及放射免疫显像的初步研究[J].现代肿瘤医学,2006,14(6):710-712. 被引量:2
  • 2左强,张军一,陈锦章,罗荣城.^(131)I标记抗CD20单克隆抗体在荷瘤裸鼠体内的放射免疫显像[J].肿瘤防治研究,2007,34(7):473-476. 被引量:3
  • 3HUNG M C,LAU Y K.Basic science of HER-2/neu:a review[J].Semin Oncol,1999,26(4):51-59.
  • 4ANDERSSON H,CEDERKRANTZ E,BACK T,et al.Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients:pharmacokinetics and dosimetry of 211At-MX35F(ab')2-a phase Ⅰstudy[J].J Nucl Med,2009,50(7):1153-1160.
  • 5MANDLER R,KOBAYASHI H,HINSON E R,et al.Herceptin-Geldanamycin immunocojugates:pharmacokinetics,biodistribution,and enhanced antitumor activity[J].Cancer Res,2004,64(4):1460-1467.
  • 6HAJJAR G,SHARKEY R M,BURTON J,et al.Phase Ⅰ radioimmunotherapy trial with iodine-131-labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer[J].Clin Colorectal Cancer,2002,2(1):31-42.
  • 7BLEND M J,STASTNY J J,SWANSON S M,et al.Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent[J].Cancer Biother Radio-pharm,2003,18(3):355-363.
  • 8ROSENBLUM M G,VERCHRAEGEN C F,MURRAY J L,et al.Phase Ⅰ study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer effect of dose and EDTA coadministration on pharmacokinetics and toxicity[J].Clin Cancer Res,1999,5(5):953-961.
  • 9GOLD D V,SCHUTSKY K,MODRAK D,et al.Low-dose radioimmunotherapy(90Y-PAM4)combined with gemcitabine for the treatment of experimental pancreatic cancer[J].Clin Cancer Res,2003,9(10 Pt 2):3929-3937.
  • 10EL-DEIRY W S,HARPER J W,O'CONNOR P M,et al.WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis[J].Cancer Res,1994,54(5):1169-1174.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部